Terri S. Armstrong, Ph.D., N.P.
Affiliations: | 1996-2000 | Neurosurgery | Winship Cancer Institue, Emory University |
2000-2016 | Neuro-Oncology | M.D. Anderson Cancer Center, Houston, TX, United States | |
2003-2016 | School of Nursing | University of Texas, Health Science Center at Houston | |
2016- | Neuro-Oncology Branch | CCR, NCI, NIH |
Area:
symptom assessment, management, myelotoxicityWebsite:
https://nursing.uth.edu/directory/profile/index.htm?profileinode=f1040d2a-3e1a-472f-9171-479f7af0f4dcGoogle:
"Terri Armstrong"Mean distance: 106866
Children
Sign in to add traineeSeema Aggarwal | grad student | University of Texas, Health Science Center at Houston | |
Jennifer Cahill | grad student | University of Texas, Health Science Center at Houston | |
Amanda King | grad student | National Cancer Institute, NIH, Bethesda | |
Julie Walker | grad student | University of Texas, Health Science Center at Houston | |
Dorela Doris Shuboni-Mulligan | post-doc | 2017-2022 | National Cancer Institue-NIH |
Collaborators
Sign in to add collaboratorNational Brain Tumor Society | collaborator | National Brain Tumor Society |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Stockdill ML, King A, Johnson M, et al. (2024) The relationship between social determinants of health and neurocognitive and mood-related symptoms in the primary brain tumor population: A systematic review. Neuro-Oncology Practice. 11: 226-239 |
Price M, Neff C, Nagarajan N, et al. (2024) CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020. Neuro-Oncology. 26: iii1-iii53 |
Rogers JL, Wall T, Acquaye-Mallory AA, et al. (2024) Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors. Journal of Neuro-Oncology |
Briceno N, Vera E, Komlodi-Pasztor E, et al. (2024) Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings. Neuro-Oncology Advances. 6: vdae019 |
Li A, Hancock JC, Quezado M, et al. (2023) TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma. Neuro-Oncology Advances. 6: vdad164 |
Byrne EM, Pascoe M, Cooper D, et al. (2023) Challenges and limitations of clinical trials in the adolescent and young adult CNS cancer population: A systematic review. Neuro-Oncology Advances. 6: vdad159 |
Cherng HR, Sun K, Bentzen S, et al. (2023) Evaluating the Heterogeneity of Hippocampal Avoidant Whole Brain Radiotherapy Treatment Effect: A Secondary Analysis of NRG CC001. Neuro-Oncology |
Price M, Neff C, Kruchko C, et al. (2023) Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT. Journal of Neuro-Oncology. 165: 279-290 |
Adegbesan KA, Tomassoni Ardori F, Yanpallewar S, et al. (2023) The sex-dependent impact of PER2 polymorphism on sleep and activity in a novel mouse model of cranial-irradiation-induced hypersomnolence. Neuro-Oncology Advances. 5: vdad108 |
Kim Y, Gilbert MR, Armstrong TS, et al. (2023) Clinical outcome assessment trends in clinical trials-Contrasting oncology and non-oncology trials. Cancer Medicine |